# Hangzhou Puju Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hangzhou-puju-medical-technology-co

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.expeclin.com
- Total disclosed funding: $34M
- Latest round: Series A (Jun 24, 2022)
- Investors on record: 5

## About

Established in 2020 and based in Hangzhou, China, Hangzhou Puju Medical Technology Co., Ltd is a pharmaceutical company that focuses on developing complementary kits for maternal and child genetics, nutritional levels, therapeutic drug testing, metabolic monitoring, and other products.

The main business is related to clinical trace element and small molecule metabolite testing, mainly including the production, R&D and sales of medical single-rod or triple quadrupole inductively coupled plasma mass spectrometry trace element analyzer, triple quadrupole liquid chromatography tandem mass spectrometry small molecule metabolite diagnostic system and its supporting sample automatic processing system, and in vitro diagnostic kits corresponding to the above clinical instruments.

## Funding rounds

- Series A, Jun 24, 2022, $34M — Hong Shan, Focused Photonics (Hangzhou), Inc., HIIG Equity Fund, Grand Mount Capital, Shenzhen Topwin Capital Management Co.,Ltd.

## Investors

- Hong Shan — Series A
- Focused Photonics (Hangzhou), Inc. — Series A
- HIIG Equity Fund (https://capitalatlas.ai/funds/hiig-equity-fund) — Series A
- Grand Mount Capital (https://capitalatlas.ai/funds/grand-mount-capital) — Series A
- Shenzhen Topwin Capital Management Co.,Ltd. — Series A